Accéder au contenu
Merck

Enhancer-Driven Gene Expression (EDGE) Enables the Generation of Viral Vectors Specific to Neuronal Subtypes.

iScience (2020-02-23)
Rajeevkumar Raveendran Nair, Stefan Blankvoort, Maria Jose Lagartos, Cliff Kentros
RÉSUMÉ

Although a variety of remarkable molecular tools for studying neural circuits have recently been developed, the ability to deploy them in particular neuronal subtypes is limited by the fact that native promoters are almost never specific enough. We recently showed that one can generate transgenic mice with anatomical specificity surpassing that of native promoters by combining enhancers uniquely active in particular brain regions with a heterologous minimal promoter, an approach we call EDGE (Enhancer-Driven Gene Expression). Here we extend this strategy to the generation of viral (rAAV) vectors, showing that some EDGE rAAVs can recapitulate the specificity of the corresponding transgenic lines in wild-type animals, even of another species. This approach thus holds the promise of enabling circuit-specific manipulations in wild-type animals, not only enhancing our understanding of brain function, but perhaps one day even providing novel therapeutic avenues to approach disorders of the brain.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Millipore
Nucléase Benzonase® HC, pureté > 99 %, Effective Viscosity Reduction and Removal of Nucleic Acids from protein solutions